Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Daria Georgievna Tolkacheva
Effectiveness and Safety of Targeted Drugs for the Treatment of Adults With Moderate-To-Severe Plaque Psoriasis in the Russian Federation
Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)
Related publications
Pss32 - Cost-Effectiveness of Brodalumab for the Treatment of Moderate to Severe Plaque Psoriasis in Greece
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Costs of Treatment in Patients With Moderate to Severe Plaque Psoriasis
Archives of Dermatology
Efficacy and Safety of Continuous Risankizumab Therapy vs Treatment Withdrawal in Patients With Moderate to Severe Plaque Psoriasis
JAMA Dermatology
Dermatology
Medicine
Cost Per Responder for Ixekizumab and Other Biologic Drugs Approved for the Treatment of Moderate-To-Severe Plaque Psoriasis in Italy
Global and Regional Health Technology Assessment
Health Policy
Safety, Efficacy, and Drug Survival of Biologics and Biosimilars for Moderate-To-Severe Plaque Psoriasis
British Journal of Dermatology
Dermatology
Medicine
Pss30 - Cost Effectiveness of Dimethyl Fumarate (Dmf) in the Treatment of Moderate to Severe Plaque Psoriasis: A Uk Perspective
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Experience of Pain and Redness in Patients With Moderate to Severe Plaque Psoriasis
Journal of Dermatological Treatment
Dermatology
New Polymorphisms Associated With Response to Anti-TNF Drugs in Patients With Moderate-To-Severe Plaque Psoriasis
Pharmacogenomics Journal
Molecular Medicine
Genetics
Pharmacology
Randomized, Controlled Study of Bleselumab (ASKP1240) Pharmacokinetics and Safety in Patients With Moderate-To-Severe Plaque Psoriasis
Biopharmaceutics and Drug Disposition
Medicine
Pharmacology
Pharmaceutical Science